OUR SOLUTIONS

Our Solutions

The Company

BioIC Technology International Ltd. is a Hong Kong–based company dedicated to providing advanced allergy diagnostic solutions for medical professionals.

Our diagnostic products are built on a patented, next-generation microfluidic chip developed by Agnitio Science & Technology. Founded in 2001 in Hsinchu—the heart of Taiwan’s high-tech and semiconductor industries—Agnitio is recognized as a leading provider of microfluidics technology and information infrastructure for the global healthcare and life sciences sectors, with certifications and approvals demonstrate the company’s commitment to quality, patient safety, and clinical reliability.

The Technology – BioIC® Microfluidic Chip

The microfluidic chip integrates cutting-edge informatics with multiple assay technologies, including enzyme-linked immunosorbent assay (ELISA), protein array platforms, ultrasonic surface treatment, and chemiluminescence immunoassay (CLIA). Designed specifically for life science and healthcare applications, it delivers:

Next‑Gen Microfluidics for Precision Allergy Care

- High Sensitivity. Minimal Sample. Maximum Confidence.

Multiplex antigen analysis for comprehensive results, Empowering Clinicians with Rapid, Reliable Allergy Insights.
Minimal blood sample requirement for patient comfort

- Innovation in Every Drop

This integrated approach enables rapid, reliable, and cost-efficient diagnostic outcomes, empowering clinicians with actionable insights for improved patient care.

Our Products

We offer comprehensive automatic and semi-automatic machines to fit productivity needs of various laboratories.

Core competencies in allergy diagnostics - Region‑Specific Allergy Panels

We design region‑specific allergen panels that truly reflect the local allergen landscape of each territory. Unlike overcrowded global panels filled with hundreds of irrelevant allergens—which can complicate interpretation and increase costs—our solutions focus on what matters most locally, delivering clarity, efficiency, and clinical relevance.

Tailored for local needs - our panels provide clinicians with:

Precision – Built from extensive regional prevalence data and collaboration with local allergy specialists.
Efficiency – Cost‑effective testing that eliminates globally rare, irrelevant allergens.
Relevance – Smart mix of whole extracts and allergen components tailored to local clinical practice.
Guidance – Built‑in bilingual Allergy Interpretation Guide to support clear result interpretation and effective patient management.

Proven in Practice

Our flagship offerings for Hong Kong, Macau, and the Greater Bay Area include:

BioIC® South China Multiplex Panel 70 (SCMP70)
BioIC® MAX Allergy Panel

BioIC® MAX Allergy Panel was developed from 10,000 patient sera samples (2020–2025), ensuring unmatched accuracy and regional relevance.

BioIC® Microfluidics Allergy Test

Model 型號	A7A	A7B
Name of the panel	South China Multiplex Panel 70 (SCMP70)	BioIC MAX
Contents	Specific IgE vs 84 Allergens (2 special allergens, 74 extracts, 8 components) + total IgE	Specific IgE vs 71 Allergens (1 CCD, 46 extracts, 24 components) + total IgE
Features	General screening. Components are included for diet management and risk prediction. Staph enterotoxins A&B are useful for management in Eczema patients.	Tailor-made panel for HK and Macau – clinically relevant selection of allergens based on 10,000 Multiplex results in HK & Macau. Useful for complicated cases.

Download A7A leaflet

Download A7B leaflet

Certification/Approval

Certification 認證	Issuing Authority 發證機構	Significance 重要意義
Taiwan GMP Certification	Taiwan Ministry of Health and Welfare	Reinforces commitment to high-quality, compliant manufacturing in Taiwan.
Korea GMP Certification	Ministry of Food and Drug Safety, Korea	Ensures manufacturing processes meet strict Good Manufacturing Practice standards.
Malaysia FDA Approval	Ministry of Health, Malaysia	Confirms compliance with local medical device regulations for Southeast Asia.
China FDA Approval	National Medical Products Administration China	Intensive clinical data to validate sensitivities and specificities in patients
Taiwan FDA Approval	Taiwan Food and Drug Administration	Intensive clinical data to validate sensitivities and specificities in patients
CE Marking	European Union	International standard for medical device quality management systems, ensuring safety and consistency in Agnitio’s allergen profiling system. Demonstrates compliance with EU health, safety, and environmental standards; enables distribution across the European Economic Area.
ISO 13485	BSI Group	International standard for medical device quality management systems, ensuring safety and consistency in Agnitio’s allergen profiling system.

Publications of BioIC®

Fang et al. High sensitization to Rhizopus nigricans in children with allergic asthma in Southwest China: A microfluidic chip and proteomics study. World Allergy Organization Journal 2025 Aug 8;18(8):101097.
Lee et al. Cord blood IgE predicts allergic sensitization, elevation of exhaled nitric oxide, and asthma in schoolchildren. Pediatr Allergy Immunol. 2022 Aug;33(8):e13838.
Izabela Szymczak-Pajor, Rafal Pawliczak. Comparison of an automated microfluidic immunoassay technology (BioIC, lab-on-chips) and ImmunoCAP assay. Lab-on-chips as a tool for specific IgE (sIgE) detection. Postepy Dermatol Alergol 2020 Feb;37(1):56-60.
Yao et al. Tobacco smoke exposure and multiplexed immunoglobulin E sensitization in children: a population-based study. Allergy 2016 Jan;71(1):90–98.
Wang et al. Longitudinal pattern of multiplexed immunoglobulin E sensitization from prenatal stage to the first year of life. Pediatr Allergy Immunol 2016 Sep;27(6):620–626.
Yao et al. Multiplexed immunoglobulin E sensitization in relation to exhaled nitric oxide in a population sample of children. Allergy 2014 May;69(5):678-82.
Jiu-Yao Wang. What Taiwan contributes to the world of allergy and clinical immunology? Asia Pac Allergy 2013 Oct;3(4):209-214.
Yong et al. Different profiles of allergen sensitization in different ages and geographic areas in Changhua, Taiwan. J Microbiol Immunol Infect 2013 Aug;46(4):295-301.
Shyur et al. Determination of multiple allergen-specific IgE by microfluidic immunoassay cartridge in clinical settings. Pediatr Allergy Immunol 2010 Jun;21(4 Pt 1):623-33.
Tai et al. An automated microfluidic-based immunoassay cartridge for allergen screening and other multiplexed assays. Anal Biochem 2009 Aug;391(2):98–105.
EAACI WAO 2013 - poster: Comparison of BioIC® with ImmunoCAP® for Determination of Allergen-Specific IgE in a Population Sample of Asian Children: PATCH Study